Figure 1. Proportion of individuals with or without diabetes mellitus (DM) at baseline who required antidiabetic medications during immunosuppressive therapy.
(A) With DM. (B) Without DM.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.